Search
01/06/2022
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts
Ruiz, PLD, Chen, L, Morton, JI, Salim, A, Carstensen, B, Gregg, EW, Pavkov, ME, Mata-Cases, M, Mauricio, D, Nichols, GA, Santa Pildava, Read, SH, Wild, SH, Shaw, JE, Magliano, DJ. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. DIABETOLOGIA. 2022; 65(6)DOI:10.1007/s00125-022-05659-9. PMID:35314870. IF:8.200(Q1/1D).
01/06/2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Salvatori, R, Maffei, P, Webb, SM, Brue, T, Loftus, J, Valluri, SR, Gomez, R, Wajnrajch, MP, Fleseriu, M. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary. 2022; 25(3)DOI:10.1007/s11102-022-01206-2. PMID:35022929. IF:3.800(Q2/5D).
01/06/2022
An interventional nationwide surveillance program lowers postoperative infection rates in elective colorectal surgery. A cohort study (2008-2019)
Arroyo-Garcia N., Badia J.M., Vázquez A., Pera M., Parés D., Limón E., Almendral A., Piriz M., Díez C., Fraccalvieri D., López-Contreras J., Pujol M., VINCat Program. An interventional nationwide surveillance program lowers postoperative infection rates in elective colorectal surgery. A cohort study (2008-2019). International Journal of Surgery. 2022; 102DOI:10.1016/j.ijsu.2022.106611. PMID:35427799. IF:15.300(Q1/1D).
01/06/2022
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
Pombo-Suarez, M, Sanchez-Piedra, C, Ruiz-Montesino, D, Diaz-Torne, C, Jovani, V, Cea-Calvo, L, Castrejon, I. Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry. Musculoskeletal Care. 2022; 20(2)DOI:10.1002/msc.1595. PMID:34668303. IF:(Q/D).
01/06/2022
Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis
Julia, A, Gomez, A, Lopez-Lasanta, M, Blanco, F, Erra, A, Fernandez-Nebro, A, Mas, AJ, Perez-Garcia, C, Vivar, MLG, Sanchez-Fernandez, S, Alperi-Lopez, M, Sanmarti, R, Ortiz, AM, Fernandez-Cid, CM, Diaz-Torne, C, Moreno, E, Li, TL, Martinez-Mateu, SH, Absher, DM, Myers, RM, Molina, JT, Marsal, S. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. EBioMedicine. 2022; 80DOI:10.1016/j.ebiom.2022.104053. PMID:35576644. IF:11.100(Q1/1D).
01/06/2022
Multi-ancestry genome-wide association study of asthma exacerbations
Herrera-Luis, E, Ortega, VE, Ampleford, EJ, Sio, YY, Granell, R, de Roos, E, Terzikhan, N, Vergara, EE, Hernandez-Pacheco, N, Perez-Garcia, J, Martin-Gonzalez, E, Lorenzo-Diaz, F, Hashimoto, S, Brinkman, P, Jorgensen, AL, Yan, Q, Forno, E, Vijverberg, SJ, Lethem, R, Espuela-Ortiz, A, Gorenjak, M, Eng, C, Gonzalez-Perez, R, Hernandez-Perez, JM, Poza-Guedes, P, Sardon, O, Corcuera, P, Hawkins, GA, Marsico, A, Bahmer, T, Rabe, KF, Hansen, G, Kopp, MV, Rios, R, Cruz, MJ, Gonzalez-Barcala, FJ, Olaguibel, JM, Plaza, V, Quirce, S, Canino, G, Cloutier, M, Del Pozo, V, Rodriguez-Santana, JR, Korta-Murua, J, Villar, J, Potocnik, U, Figueiredo, C, Kabesch, M, Mukhopadhyay, S, Pirmohamed, M, Hawcutt, DB, Melen, E, Palmer, CN, Turner, S, Maitland-van der Zee, AH, von Mutius, E, Celedon, JC, Brusselle, G, Chew, FT, Bleecker, E, Meyers, D, Burchard, EG, Pino-Yanes, M. Multi-ancestry genome-wide association study of asthma exacerbations. PEDIATRIC ALLERGY AND IMMUNOLOGY. 2022; 33(6)DOI:10.1111/pai.13802. PMID:35754128. IF:4.400(Q1/1D).
01/06/2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
Arriola, E, Gonzalez-Cao, M, Domine, M, De Castro, J, Cobo, M, Bernabe, R, Navarro, A, Sullivan, I, Trigo, JM, Mosquera, J, Crama, L, Isla, D. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Oncology And Therapy. 2022; 10(1)DOI:10.1007/s40487-021-00182-0. PMID:35032007. IF:(Q/D).
01/06/2022
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
Majem, M, Goldman, JW, John, T, Grohe, C, Laktionov, K, Kim, SW, Kato, T, Vu, HV, Lu, S, Li, SQ, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Atagi, S, Zeng, LM, Kulkarni, D, Medic, N, Tsuboi, M, Herbst, RS, Wu, YL. Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial. CLINICAL CANCER RESEARCH. 2022; 28(11)DOI:10.1158/1078-0432.CCR-21-3530. PMID:35012927. IF:11.500(Q1/1D).